FDA 510(k) FDA class 2 Substantially Equivalent 🇺🇸 United States

COBAS C 501 TINA-QUANT HBA1CDX GEN.3 ASSAY

K Number: K121610 · Decision Aug 8, 2013
Classifications
1
FEI Numbers
34
Registration Numbers
34
Same Product Code
25
Applicant Total
5
Review Days
433

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
COBAS C 501 TINA-QUANT HBA1CDX GEN.3 ASSAY
K Number
K121610
Device Class
FDA class 2
Clearance Type
Traditional
Regulation Number
862.1373
Medical Specialty
Clinical Chemistry
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
Roche Diagnostics Operations
Date Received
June 1, 2012
Decision Date
August 8, 2013
Product Code
PDJ
Advisory Committee
Clinical Chemistry
Review Advisory Committee
CH
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
PDJ Hemoglobin A1c Test System

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (PDJ), ordered by most recent decision date.

View all

Other Clearances by Roche Diagnostics Operations

K Number Device Name
K241220 Tina-quant Lipoprotein(a) Gen.2 Molarity
K233454 ONLINE TDM Methotrexate
K163633 cobas HbA1c Test, cobas b 101 system
K113072 TINA-QUANT ALBUMIN GEN.2